NEW YORK (GenomeWeb News) – All three firms cited by the US Food and Drug Administration last week for allegedly marketing tests for the 2009 H1N1 Flu Virus, also known as the swine flu, that had not been cleared for marketing by the agency have complied with FDA's instructions, they have confirmed for GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.